Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis

Activation of trimethylation of histone 3 lysine 27 (H3K27me3) by EZH2, a component of the Polycomb repressive complex 2 (PRC2), is suggested to play a role in endometriosis. However, the mechanism by which this complex is dysregulated in endometriosis is not completely understood. Here, using eutop...

Full description

Bibliographic Details
Main Authors: Sarah Brunty, Kristeena Ray Wright, Brenda Mitchell, Nalini Santanam
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/7/3492
_version_ 1797539758538227712
author Sarah Brunty
Kristeena Ray Wright
Brenda Mitchell
Nalini Santanam
author_facet Sarah Brunty
Kristeena Ray Wright
Brenda Mitchell
Nalini Santanam
author_sort Sarah Brunty
collection DOAJ
description Activation of trimethylation of histone 3 lysine 27 (H3K27me3) by EZH2, a component of the Polycomb repressive complex 2 (PRC2), is suggested to play a role in endometriosis. However, the mechanism by which this complex is dysregulated in endometriosis is not completely understood. Here, using eutopic and ectopic tissues, as well as peritoneal fluid (PF) from IRB-approved and consented patients with and without endometriosis, the expression of PRC2 complex components, JARID2, miR-155 (known regulators of EZH2), and a key inflammatory modulator, FOXP3, was measured. A higher expression of EZH2, H3K27me3, JARID2, and FOXP3 as well as miR-155 was noted in both the patient tissues and in endometrial PF treated cells. Gain-or-loss of function of miR-155 showed an effect on the PRC2 complex but had little effect on JARID2 expression, suggesting alternate pathways. Chromatin immunoprecipitation followed by qPCR showed differential expression of PRC2 complex proteins and its associated binding partners in JARID2 vs. EZH2 pull down assays. In particular, endometriotic PF treatment increased the expression of <i>PHF19</i> (<i>p</i> = 0.0474), a gene silencer and co-factor that promotes PRC2 interaction with its targets. Thus, these studies have identified the potential novel crosstalk between miR-155-PRC2 complex-JARID2 and PHF19 in endometriosis, providing an opportunity to test other epigenetic targets in endometriosis.
first_indexed 2024-03-10T12:50:24Z
format Article
id doaj.art-7974f7b40dc34adfa8e005d3ed4b24ff
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T12:50:24Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-7974f7b40dc34adfa8e005d3ed4b24ff2023-11-21T13:08:28ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-03-01227349210.3390/ijms22073492Peritoneal Modulators of EZH2-miR-155 Cross-Talk in EndometriosisSarah Brunty0Kristeena Ray Wright1Brenda Mitchell2Nalini Santanam3Department of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USADepartment of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USADepartment of Obstetrics and Gynecology, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USADepartment of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USAActivation of trimethylation of histone 3 lysine 27 (H3K27me3) by EZH2, a component of the Polycomb repressive complex 2 (PRC2), is suggested to play a role in endometriosis. However, the mechanism by which this complex is dysregulated in endometriosis is not completely understood. Here, using eutopic and ectopic tissues, as well as peritoneal fluid (PF) from IRB-approved and consented patients with and without endometriosis, the expression of PRC2 complex components, JARID2, miR-155 (known regulators of EZH2), and a key inflammatory modulator, FOXP3, was measured. A higher expression of EZH2, H3K27me3, JARID2, and FOXP3 as well as miR-155 was noted in both the patient tissues and in endometrial PF treated cells. Gain-or-loss of function of miR-155 showed an effect on the PRC2 complex but had little effect on JARID2 expression, suggesting alternate pathways. Chromatin immunoprecipitation followed by qPCR showed differential expression of PRC2 complex proteins and its associated binding partners in JARID2 vs. EZH2 pull down assays. In particular, endometriotic PF treatment increased the expression of <i>PHF19</i> (<i>p</i> = 0.0474), a gene silencer and co-factor that promotes PRC2 interaction with its targets. Thus, these studies have identified the potential novel crosstalk between miR-155-PRC2 complex-JARID2 and PHF19 in endometriosis, providing an opportunity to test other epigenetic targets in endometriosis.https://www.mdpi.com/1422-0067/22/7/3492endometriosisepigeneticsEZH2microRNA
spellingShingle Sarah Brunty
Kristeena Ray Wright
Brenda Mitchell
Nalini Santanam
Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis
International Journal of Molecular Sciences
endometriosis
epigenetics
EZH2
microRNA
title Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis
title_full Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis
title_fullStr Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis
title_full_unstemmed Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis
title_short Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis
title_sort peritoneal modulators of ezh2 mir 155 cross talk in endometriosis
topic endometriosis
epigenetics
EZH2
microRNA
url https://www.mdpi.com/1422-0067/22/7/3492
work_keys_str_mv AT sarahbrunty peritonealmodulatorsofezh2mir155crosstalkinendometriosis
AT kristeenaraywright peritonealmodulatorsofezh2mir155crosstalkinendometriosis
AT brendamitchell peritonealmodulatorsofezh2mir155crosstalkinendometriosis
AT nalinisantanam peritonealmodulatorsofezh2mir155crosstalkinendometriosis